These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7532762)

  • 21. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lidocaine's effect on defibrillation threshold are dependent on the defibrillation electrode system: epicardial versus endocardial.
    Winecoff Miller AP; Sims JJ; McSwain R; Ujhelyi MR
    J Cardiovasc Electrophysiol; 1998 Mar; 9(3):312-20. PubMed ID: 9554736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function.
    Stambler BS; Beckman KJ; Kadish AH; Camm JA; Ellenbogen KA; Perry KT; VanderLugt JT
    Am J Cardiol; 1997 Aug; 80(4):458-63. PubMed ID: 9285658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?
    Murakawa Y; Yamashita T; Kanese Y; Omata M
    J Am Coll Cardiol; 1997 Mar; 29(3):688-92. PubMed ID: 9060912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
    Dorian P; Newman D
    Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model.
    Siden R; Kadish A; Flowers W; Kutas L; Bieneman BK; DePietro J; Jenkins JP; Gallagher KP; Levy RJ
    J Cardiovasc Pharmacol; 1992 May; 19(5):798-809. PubMed ID: 1381779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class III antiarrhythmic effects of LY-190147 on defibrillation threshold.
    Beatch GN; Dickenson DR; Wood RH; Tang AS
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):218-25. PubMed ID: 8720420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
    Mehdirad AA; Carnes CA; Nelson SD
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):147-51. PubMed ID: 9990620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered response to ibutilide in a heart failure model.
    Chugh SS; Johnson SB; Packer DL
    Cardiovasc Res; 2001 Jan; 49(1):94-102. PubMed ID: 11121800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation.
    Sun JL; Han R; Guo JH; Li XY; Ma XL; Wang CY
    Cell Biochem Biophys; 2012 Dec; 64(3):197-203. PubMed ID: 22740072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide.
    Chen YJ; Hsieh MH; Chiou CW; Chen SA
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):237-47. PubMed ID: 10445675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization.
    Siden R; Flowers WE; Levy RJ
    Biomaterials; 1992; 13(11):764-70. PubMed ID: 1391398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ibutilide on the canine cardiac conduction system.
    Sun JL; Han R; Guo JH; Li XY; Ma XL; Wang CY
    Cell Biochem Biophys; 2012 Nov; 64(2):161-8. PubMed ID: 22729888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes: studies in the canine sterile pericarditis model.
    Ortiz J; Sokoloski MC; Ayers GM; Cmolik BL; Niwano S; Geha AS; Waldo AL
    J Am Coll Cardiol; 1995 Nov; 26(5):1356-64. PubMed ID: 7594054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transthoracic defibrillation of short-lasting ventricular fibrillation: a randomised trial for comparison of the efficacy of low-energy biphasic rectilinear and monophasic damped sine shocks.
    Szili-Torok T; Theuns D; Verblaauw T; Scholten M; Kimman GJ; Res J; Jordaens L
    Acta Cardiol; 2002 Oct; 57(5):329-34. PubMed ID: 12405569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs.
    Zhou X; Daubert JP; Wolf PD; Smith WM; Ideker RE
    Circ Res; 1993 Jan; 72(1):145-60. PubMed ID: 8417837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs.
    Schräder R; Brooks M; Echt DS
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):839-50. PubMed ID: 1376802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.